Bermuda vs Bulgaria: Tuberculosis patients living with HIV receiving antiretroviral therapy
Bermuda
0 patients
in 2021
Bulgaria
0 patients
in 2021
Bermuda rank
141st
Bulgaria rank
141st
Tuberculosis patients living with HIV receiving antiretroviral therapy over time
- Bermuda
- Bulgaria
How they compare
Bermuda currently reports 0 patients against 0 patients in Bulgaria, a difference of 0 patients.
Across all 12 years both countries report, Bulgaria has been ahead every year.
Bermuda ranks 141st and Bulgaria ranks 141st of 183 countries.
Bulgaria has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Bermuda | Bulgaria | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0 patients | 3.33 patients | 3.33 patients | Bulgaria |
| 2010s | 0 patients | 2 patients | 2 patients | Bulgaria |
| 2020s | 0.5 patients | 0.5 patients | 0 patients | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher tuberculosis patients living with hiv receiving antiretroviral therapy, Bermuda or Bulgaria?
- Bermuda, at 0 patients against 0 patients in Bulgaria as of 2021.
- What is the difference in tuberculosis patients living with hiv receiving antiretroviral therapy between Bermuda and Bulgaria?
- 0 patients, with Bermuda ahead.
- How many years of comparable data are there for Bermuda and Bulgaria?
- 12 years are reported by both, from 2003 to 2021.
- How do Bermuda and Bulgaria rank globally for tuberculosis patients living with hiv receiving antiretroviral therapy?
- Bermuda ranks 141st and Bulgaria ranks 141st of 183 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026); Population based on various sources (2024) – with minor processing by Our World in Data, published as Tuberculosis patients living with HIV receiving antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of tuberculosis patients who are living with HIV and receiving antiretroviral therapy.